The Hepatobiliary Research Group, led by Dr. Christian Stöß in the Department of Surgery, investigates the cellular and molecular mechanisms driving metabolic liver disease, inflammation, fibrosis, regeneration, and liver cancer. 

By integrating clinical data, patient-derived samples, preclinical models, advanced imaging, and ex vivo liver models, we study how immune cells, regulated cell death, and the hepatic microenvironment influence disease progression, tissue repair, and postoperative recovery. Our goal is to identify novel therapeutic targets and translate mechanistic insights into improved treatments for patients with hepatobiliary diseases and those undergoing liver surgery.